pCAD-POAF 3 Year Follow-up

Sex: All

Ages: 18 Years – 85 Years

Healthy volunteers: No

Enrollment: 430

Sponsor: China National Center for Cardiovascular Diseases

Summary

This study will include the subjects who enrolled in pCAD-POAF trial (NCT05009914) to observe clinical outcomes 3 years after surgery. The primary outcome is the time to first occurrence of a composite of all-cause death, stroke, systemic embolism, myocardial infarction, unplanned cardiac rehospitalization, or post-discharge atrial fibrillation from randomization through 3 years after surgery. The secondary outcomes are：the individual components of the primary composite outcome; unplanned all-cause rehospitalization; arrhythmias other than atrial fibrillation; premature atrial contraction and premature ventricular contraction burdens; heart rate variability parameters; quality-of-life scores; and other Holter-derived parameters.

Eligibility Criteria

Inclusion Criteria: * This study will include the subjects who enrolled in pCAD-POAF trial Exclusion Criteria: * This study will include the subjects who enrolled in pCAD-POAF trial

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07146061). StuddyBuddy aggregates publicly available trial information.